✦ LIBER ✦

The evaluation of amifostine for mucosal protection in patients with advanced loco-regional Squamous Cell Carcinomas of the Head and Neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily Radiotherapy (RT)

✍ Scribed by Mohan Suntharalingam; Jerry Jaboin; Rodney Taylor; Jeffrey Wolf; Madan Banglore; David Van Echo; Robert Ord

Book ID: 114473715
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 93 KB
Volume: 31
Category: Article
ISSN: 0093-7754
DOI: 10.1053/j.seminoncol.2005.02.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Study Evaluating the Addition o

Phase II Study Evaluating the Addition of Cetuximab to the Concurrent Delivery of Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy for Patients With Locally Advanced Squamous Cell Carcinomas of the Head and Neck

✍ Mohan Suntharalingam; Young Kwok; Olga Goloubeva; Arti Parekh; Rodney Taylor; Je 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Phase II randomized study of concomitant

Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck

✍ Robert Haddad; Lori Wirth; Rosemary Costello; Linda Weeks; Marshall Posner 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Comparison of hyperfractionation and con

Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

✍ Hideaki Katori; Mamoru Tsukuda; Kiichi Watai 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 319 KB

Phase I and initial phase II results fro

Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck

✍ David L. Schwartz; R. Bruce Montgomery; Bevan Yueh; Michael Donahue; Yoshimi Anz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Abstract ## BACKGROUND The current Phase I/II study assessed induction docetaxel/carboplatin given weekly for 4 weeks, followed by weekly docetaxel/carboplatin and concomitant boost radiotherapy (CB‐XRT) for locally advanced head and neck squamous cell carcinoma. ## METHODS Twenty patients wi

Hyperfractionated radiotherapy (Hfx RT)

Hyperfractionated radiotherapy (Hfx RT) with or without concurrent low-dose daily cisplatin (CDDP) in locally advanced unresectable squamous cell carcinoma of the head and neck (SCC H&N). A prospective randomized trial

✍ B. Jeremic; Y. Shibamoto; B. Milicic; N. Nikolic; A. Dagovic 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 186 KB